An illustration of DNA attached to magnetic beads, as used in the single molecule microscope Professor Mark Szczelkun
An international team of scientists has made a major step forward in our understanding of how enzymes ‘edit’ genes, paving the way for correcting genetic diseases in patients.
Researchers at the Universities of Bristol, Münster and the Lithuanian Institute of Biotechnology have observed the process by which a class of enzymes called CRISPR – pronounced ‘crisper’ – bind and alter the structure of DNA.
The results, published in the Proceedings of the National Academy of Sciences (PNAS) today [26 May], provide a vital piece of the puzzle if these genome editing tools are ultimately going to be used to correct genetic diseases in humans.
Read more . . .
The Latest on: Correcting genetic diseases
via Google News
The Latest on: Correcting genetic diseases
- Krystal Biotech Announces Virtual Presentation of Pre-clinical Data on KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency at ESGCTon October 14, 2021 at 5:52 am
Krystal Biotech Announces Virtual Presentation of Pre-clinical Data on KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency at ESGCT. PITTSBURGH, Oct. 14, 2021 (GLOBE NEWSWIR ...
- Study identifies DNA mutations linking liver disease with obesity and diabeteson October 13, 2021 at 5:43 pm
For the first time, DNA mutations in liver cells have been identified that impact metabolism and insulin sensitivity in patients with liver disease.
- Mutations in liver cells linked to liver disease and fat metabolismon October 13, 2021 at 9:58 am
For the first time, DNA mutations in liver cells have been identified that impact metabolism and insulin sensitivity in patients with liver disease. These mutations are specific to liver disease that ...
- Single-Cell Analysis Identifies Somatic Genetic Rescue in Pediatric Blood Disorderon October 8, 2021 at 5:00 am
Single-cell DNA analysis identifies “battle of clones” in pediatric myelodysplastic syndrome patients whose cells may self-correct.
- NEOGEN partners with Hendrix Geneticson September 30, 2021 at 5:50 pm
NEOGEN Corporation announces that it has partnered with Hendrix Genetics, a multi-species animal breeding, genetics and technology company. Through this partnership, NEOGEN will support the ...
- How to take race out of the equation for kidney disease diagnosison September 30, 2021 at 8:01 am
More than 20 years ago, race, specifically Black race, was factored into the calculation to diagnose kidney disease. The race factor was believed to “correct” a previous formula to better diagnose ...
- Rocket Pharmaceuticals to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conferenceon September 30, 2021 at 4:00 am
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announced that Gaurav ...
- In vivo gene editing grabs the spotlight after Intellia triumph, but challenges loomon September 29, 2021 at 12:55 am
But there is a limited number of diseases one can treat that way,” Jantz said in an interview with Fierce Biotech. “To treat the vast majority of genetic diseases, you have to deliver your ...
- 10-year-old Hong Kong boy born with incurable disease undergoes risky operation to help him breathe easieron September 28, 2021 at 4:18 pm
Marcus Ng, who suffers from spinal muscular atrophy, underwent an eight-hour operation to correct a twist in his spine that was making breathing almost impossible.
- CORRECTION: Rhythm Pharmaceuticals, Inc.on September 21, 2021 at 5:05 pm
RYTM), a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare genetic diseases of obesity, today announced that Great Britain’s Medicines ...
via Bing News
